← All patents

US11925642B2

Regulation of eIF4E activity for migraine therapy

University of Texas System

Abstract

The present disclosure provides a method of preventing, treating, or inhibiting migraine in a subject, by administering to the subject an amount of first therapeutic selected from cercosporamide, eFT508, or 4EGI-1 sufficient to prevent, treat, or inhibit said migraine. The present disclosure …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Greg Dussor
Priority date
October 08, 2020
Filing date
October 07, 2021
Grant date
March 12, 2024
Publication date
March 12, 2024
Language
en
Metadata fetched
August 29, 2026 00:32